Compare
Kraig Biocraft Laboratories, Inc. vs Hong Yuan Holding Group vs PureCycle Technologies, Inc. vs AdvanSix Inc.
| Latest fiscal year | Kraig Biocraft Laboratories, Inc. KBLB | Hong Yuan Holding Group HGYN | PureCycle Technologies, Inc. PCT | AdvanSix Inc. ASIX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | n/a | $837.8K | $8.36M | $1.52B |
| Revenue growth (YoY) | n/a | +241.1% | n/a | +0.3% |
| Gross margin | n/a | 64.4% | n/a | 10.8% (computed) |
| Operating margin | n/a | 21.1% | n/m | n/a |
| Net margin | n/a | 18.5% | n/m | 3.2% |
| Net income | -$3.62M | $155.3K | -$182.56M | $49.29M |
| EPS (Diluted) | $0.00 | $0.00 | -$1.21 | $1.80 |
| Operating cash flow | -$1.79M | -$26.4K | -$142.74M | $122.86M |
| Free cash flow | -$1.79M | n/a | -$183.59M | $6.42M |
| Cash & equivalents | $1.79M | $16.7K | $156.69M | $19.77M |
| Total assets | $2.57M | $611.3K | $922.67M | $1.71B |
| Total liabilities | $10.56M | $591.7K | $572.08M | $890.93M |
| Shareholders' equity | -$8.00M | -$62.7K | $45.89M | $815.22M |
| Return on year-end equity | n/a | n/a | -397.9% | 6.0% |
| Shares outstanding | n/a | 74.64M | 180.28M | 26.86M |
Revenue, most recent five fiscal years
| Fiscal year | Kraig Biocraft Laboratories, Inc. | Hong Yuan Holding Group | PureCycle Technologies, Inc. | AdvanSix Inc. |
|---|---|---|---|---|
| Latest | $401.6K Ended 2018-12-31 | $837.8K Ended 2025-12-31 | $8.36M Ended 2025-12-31 | $1.52B Ended 2025-12-31 |
| 1 year earlier | $97.3K Ended 2017-12-31 | $245.6K Ended 2024-12-31 | $0 Ended 2024-12-31 | $1.52B Ended 2024-12-31 |
| 2 years earlier | $31.9K Ended 2016-12-31 | n/a | $0 Ended 2023-12-31 | $1.53B Ended 2023-12-31 |
| 3 years earlier | $0 Ended 2015-12-31 | n/a | n/a | $1.95B Ended 2022-12-31 |
| 4 years earlier | $0 Ended 2014-12-31 | n/a | n/a | $1.68B Ended 2021-12-31 |